In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods

Por Pfaller, Michael A., Duncanson, Frederick, Messer, Shawn A., Moet, Gary J., Jones, Ronald N., Castanheira, Mariana
Publicado em 2011

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Por Castanheira, Mariana, Duncanson, Frederick P., Diekema, Daniel J., Guarro, Josep, Jones, Ronald N., Pfaller, Michael A.
Publicado em 2012

Madurella mycetomatis Is Highly Susceptible to Ravuconazole

Por Ahmed, Sarah Abdalla, Kloezen, Wendy, Duncanson, Frederick, Zijlstra, Ed E., de Hoog, G. Sybren, Fahal, Ahmed H., van de Sande, Wendy W. J.
Publicado em 2014

The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans

Por Wiederhold, Nathan P., Najvar, Laura K., Fothergill, Annette W., McCarthy, Dora I., Bocanegra, Rosie, Olivo, Marcos, Kirkpatrick, William R., Everson, Michael P., Duncanson, Frederick P., Patterson, Thomas F.
Publicado no Antimicrob Agents Chemother (2014)

Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE

Por Nielsen, Travis B., Pantapalangkoor, Paul, Yan, Jun, Luna, Brian M., Dekitani, Ken, Bruhn, Kevin, Tan, Brandon, Junus, Justin, Bonomo, Robert A., Schmidt, Ann Marie, Everson, Michael, Duncanson, Frederick, Doherty, Terence M., Lin, Lin, Spellberg, Brad
Publicado no mBio (2017)